Julio Chalela to Tissue Plasminogen Activator
This is a "connection" page, showing publications Julio Chalela has written about Tissue Plasminogen Activator.
Connection Strength
0.500
-
Early magnetic resonance imaging findings in patients receiving tissue plasminogen activator predict outcome: Insights into the pathophysiology of acute stroke in the thrombolysis era. Ann Neurol. 2004 Jan; 55(1):105-12.
Score: 0.181
-
Safety of air medical transportation after tissue plasminogen activator administration in acute ischemic stroke. Stroke. 1999 Nov; 30(11):2366-8.
Score: 0.135
-
MRI screening before standard tissue plasminogen activator therapy is feasible and safe. Stroke. 2005 Sep; 36(9):1939-43.
Score: 0.050
-
Diagnostic and prognostic value of early MR Imaging vessel signs in hyperacute stroke patients imaged <3 hours and treated with recombinant tissue plasminogen activator. AJNR Am J Neuroradiol. 2005 Mar; 26(3):618-24.
Score: 0.049
-
Update on stroke. Curr Opin Neurol. 2004 Aug; 17(4):447-51.
Score: 0.047
-
The safety and efficacy of thrombolysis for strokes after cardiac catheterization. J Am Coll Cardiol. 2008 Mar 04; 51(9):906-11.
Score: 0.015
-
Early blood-brain barrier disruption in human focal brain ischemia. Ann Neurol. 2004 Oct; 56(4):468-77.
Score: 0.012
-
Impact of establishing a primary stroke center at a community hospital on the use of thrombolytic therapy: the NINDS Suburban Hospital Stroke Center experience. Stroke. 2003 Jun; 34(6):e55-7.
Score: 0.011